Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the FoF Domestic median (148 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 05 Aug 2022 – 20 Aug 2026, limited by Quantum Nifty 50 ETF FOF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Quantum Nifty 50 ETF FOF | Nifty 50 |
|---|---|---|
| 05 Aug 2022 | ₹100.00 | ₹100.00 |
| 06 Dec 2022 | ₹107.26 | ₹107.16 |
| 08 Apr 2023 | ₹101.28 | ₹101.16 |
| 09 Aug 2023 | ₹113.60 | ₹112.85 |
| 10 Dec 2023 | ₹121.74 | ₹120.53 |
| 11 Apr 2024 | ₹131.97 | ₹130.79 |
| 12 Aug 2024 | ₹141.88 | ₹139.95 |
| 13 Dec 2024 | ₹144.65 | ₹142.37 |
| 15 Apr 2025 | ₹136.41 | ₹134.09 |
| 16 Aug 2025 | ₹144.99 | ₹141.58 |
| 17 Dec 2025 | ₹152.16 | ₹148.40 |
| 19 Apr 2026 | ₹143.35 | ₹139.98 |
| 20 Aug 2026 | ₹143.76 | ₹139.28 |
| Metric | Quantum · Regular NAV ₹14.38 Very High risk ★★☆☆☆ | Category median FoF Domestic · 148 funds |
|---|---|---|
| -2.77% | +7.03% | |
| +8.68% | +13.88% | |
| — | +11.19% | |
| — | +11.61% | |
| +9.40% | +10.54% | |
| +6.23% | — | |
| +11.81% | +12.35% | |
| — | +10.37% | |
| — | +8.94% | |
| Risk | ||
| 12.33% | 15.84% | |
| 0.18 | 0.70 | |
| 0.25 | 0.97 | |
| -15.49% | -19.67% | |
| Nifty 50 | — | |
| +0.78% | +1.35% | |
| 0.98 | 0.94 | |
| 100.0% | 97.2% | |
| 94.5% | 93.6% | |
| 0.19% | 0.58% | |
| ₹34.68Cr | ₹226.32Cr | |
| None | — | |
| None | — | |
| ₹500 | — | |
| ₹500 | — | |
| — | 10% | |
| Hitendra Parekh · 4.1y | — | |
| 05 Aug 2022 | — | |
| — | — | |
| — | — | |
| -0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.